SPRY2 is an important molecule for signal regulation in vivo, and the deletion of SPRY2 can lead to the activation of the PI3K/Akt/mTOR and MAPK/ERK signaling pathways, promote cell proliferation and migration, and lead to the development of hepatoma in vivo (36–38). Here, MTOR is linked to hepatocellular carcinoma.